Mark B. Feinberg - Concepedia

Author

Mark B. Feinberg

Also Known As

M B Feinberg, M Feinberg, M. B. Feinberg, M. Feinberg, M.B. Feinberg, MARK B. FEINBERG, Mandi A. Feinberg, Mark B Feinberg, Mark B. Feinberg, Mark Feinberg

152

Publications

15.8K

Citations

H-Index

Concepts

All Affiliations

Emory University Gladstone Institutes National Institutes of Health International AIDS Vaccine Initiative Harvard University

About

Mark B. Feinberg is an author at Emory University specializing in medicine, immunology, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	45	63	12.4K
2	Natural Sciences	4	4	1.2K
3	Public Health	2	2	217
4	Health Sciences	1	1	15
5	Social Sciences	1	1	26

Mark B. Feinberg

Publications

14.5K

Citations

H-Index

Page 1

	Year	Citations
Changes in thymic function with age and during the treatment of HIV infection Daniel C. Douek, Richard McFarland, Philip Keiser, Nature Primary ImmunodeficiencyHuman RetrovirusHiv InfectionImmunologyAntiviral Response	1998	1.9K
HTLV-III expression and production involve complex regulation at the levels of splicing and translation of viral RNA Mark B. Feinberg, Ruth F. Jarrett, Anna Aldovini, Cell Transcriptional RegulationViral ReplicationMolecular VirologyNatural SciencesRna Splicing	1986	675
Nonpathogenic SIV Infection of Sooty Mangabeys Is Characterized by Limited Bystander Immunopathology Despite Chronic High-Level Viremia Guido Silvestri, Donald L. Sodora, Richard A. Koup, Immunity Nonpathogenic Siv InfectionViral PersistencePathogen TransmissionChronic High-level ViremiaPathogenesis	2003	636
Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus Joseph M. McCune, Linda Rabin, Mark B. Feinberg, Cell Viral ReplicationMolecular VirologyEndoproteolytic CleavageHuman RetrovirusPathogenesis	1988	612
Human Effector and Memory CD8+ T Cell Responses to Smallpox and Yellow Fever Vaccines Joseph D. Miller, Robbert van der Most, Rama Akondy, Immunity VaccinationHuman EffectorVaccine TargetImmunologyAutoimmunity	2008	607
Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein Jeffrey D. Lifson, Mark B. Feinberg, Gregory R. Reyes, Nature Htlv-iii/lav Envelope GlycoproteinImmunologyAntiviral ResponseAntigen ProcessingAdult T-cell Leukemia-lymphoma	1986	590
The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages. Michael D. Miller, M T Warmerdam, Isabelle Gaston, The Journal of Experimental Medicine Viral ReplicationPbmc InfectionsImmunologyViral InfectionViral Persistence	1994	527
Regulation of the human interleukin-2 receptor α chain promoter: Activation of a nonfunctional promoter by the transactivator gene of HTLV-I Sharon L. Cross, Mark B. Feinberg, Julie Wolf, Cell CytokineTranscriptional RegulationTransactivator GeneHuman RetrovirusImmunology	1987	420
Activation of interleukin 2 and interleukin 2 receptor (Tac) promoter expression by the trans-activator (tat) gene product of human T-cell leukemia virus, type I. Miriam Siekevitz, Mark B. Feinberg, Nikki J. Holbrook, Proceedings of the National Academy of Sciences Gene ProductT-regulatory CellImmunologyImmune RegulationImmunologic Mechanism	1987	404
Divergent TLR7 and TLR9 signaling and type I interferon production distinguish pathogenic and nonpathogenic AIDS virus infections Judith N. Mandl, Ashley P. Barry, Thomas H. Vanderford, Nature Medicine Divergent Tlr7Human RetrovirusPathogenesisViral PathogenesisImmunology	2008	370

Page 1